This dataset provides the prescription count for opioid, benzodiazepine, stimulant, gabapentin, & naloxone dispensations in the state. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS).

This dataset provides the prescription counts and rates by town for opioid, benzodiazepine, stimulant, gabapentin, & naloxone dispensations.

This dataset provides the prescription counts and rates by town for opioid, benzodiazepine, stimulant, gabapentin, & naloxone dispensations.

This dataset provides the prescription counts and rates by town for opioid, benzodiazepine, stimulant, gabapentin, & naloxone dispensations.

This dataset includes the amount of Schedule V prescription drugs, dispensed over a 3-month span. On the controlled substance Schedule II-V; Schedule V prescription drugs have a lower potential for abuse relative to substances in Schedule IV. Schedule V prescription drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.

This dataset shows the number of gateway licensees and searches. The gateway allows providers to search the patients directly through their electronic health records (EHRs).

This dataset includes the amount of Schedule IV prescription drugs dispensed over a 3-month span, with the quarter ending March 2023. On the controlled substance Schedule II-V; Schedule IV prescription drugs have a low potential for abuse and low risk for dependence. Schedule IV drugs may be used for pain control.

This dataset provides the number & percentage of veterinarian prescriptions for gabapentin, benzodiazepine, & opiate agonist dispensations. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS).

This dataset shows how dispensed prescriptions were paid for.

This dataset provides the prescription counts and rates by town for opioid, benzodiazepine, stimulant, gabapentin, & naloxone dispensations.